BOBULSKY SUSAN 4
4 · Adaptive Biotechnologies Corp · Filed Aug 14, 2020
Insider Transaction Report
Form 4
BOBULSKY SUSAN
Chief Commercial Officer, MRD
Transactions
- Award
Stock Option (Right to Buy)
2020-08-13+20,000→ 20,000 totalExercise: $39.50Exp: 2030-08-13→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The options vest with respect to 1/4 of such shares on August 6, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.